Trial · NCT00102440
Adverse events183
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 183
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea (Excl Infective) | Gastrointestinal disorders | Febuxostat 80 mg QD | 27 | 256 | |
| other | Diarrhoea (Excl Infective) | Gastrointestinal disorders | Febuxostat 120 mg QD | 25 | 251 | |
| other | Diarrhoea (Excl Infective) | Gastrointestinal disorders | Allopurinol 300 mg QD | 16 | 253 | |
| other | Nausea and Vomiting Symptoms | Gastrointestinal disorders | Febuxostat 80 mg QD | 19 | 256 | |
| other | Nausea and Vomiting Symptoms | Gastrointestinal disorders | Febuxostat 120 mg QD | 13 | 251 | |
| other | Nausea and Vomiting Symptoms | Gastrointestinal disorders | Allopurinol 300 mg QD | 8 | 253 | |
| other | Oedema NEC | General disorders | Febuxostat 80 mg QD | 18 | 256 | |
| other | Oedema NEC | General disorders | Febuxostat 120 mg QD | 8 | 251 | |
| other | Oedema NEC | General disorders | Allopurinol 300 mg QD | 8 | 253 | |
| other | Influenza Viral Infections | Infections and infestations | Febuxostat 80 mg QD | 12 | 256 | |
| other | Influenza Viral Infections | Infections and infestations | Febuxostat 120 mg QD | 13 | 251 | |
| other | Influenza Viral Infections | Infections and infestations | Allopurinol 300 mg QD | 12 | 253 | |
| other | Lower Respiratory Tract and Lung Infections | Infections and infestations | Febuxostat 80 mg QD | 13 | 256 | |
| other | Lower Respiratory Tract and Lung Infections | Infections and infestations | Febuxostat 120 mg QD | 7 | 251 | |
| other | Lower Respiratory Tract and Lung Infections | Infections and infestations | Allopurinol 300 mg QD | 8 | 253 | |
| other | Upper Respiratory Tract Infections | Infections and infestations | Febuxostat 80 mg QD | 77 | 256 | |
| other | Upper Respiratory Tract Infections | Infections and infestations | Febuxostat 120 mg QD | 53 | 251 | |
| other | Upper Respiratory Tract Infections | Infections and infestations | Allopurinol 300 mg QD | 72 | 253 | |
| other | Limb Injuries NEC (Including [Incl] Traumatic Amputation) | Injury, poisoning and procedural complications | Febuxostat 80 mg QD | 12 | 256 | |
| other | Limb Injuries NEC (Including [Incl] Traumatic Amputation) | Injury, poisoning and procedural complications | Febuxostat 120 mg QD | 10 | 251 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00102440/events